LivaNova Sued For €21M Over Soured Heart Biz Acquisition
LivaNova is facing a €21 million ($23 million) lawsuit over allegations by a private equity firm that the medical technology giant failed to disclose supplier changes, price hikes and damaged laboratories...To view the full article, register now.
Already a subscriber? Click here to view full article